Compugen Ltd. (CGEN) Reports First Quarter 2013 Financial Results
4/25/2013 8:54:46 AM
More...
|
Compugen Ltd. (CGEN) to Present at the 12th Annual Needham Healthcare Conference
4/23/2013 6:11:50 AM
More...
|
Compugen Ltd. (CGEN) Discloses Focused Target Discovery Program for Antibody-Drug Conjugate Cancer Therapy
4/17/2013 11:24:00 AM
More...
|
Compugen Ltd. (CGEN) Reports Fourth Quarter and Calendar 2012 Financial Results
2/20/2013 6:28:25 AM
More...
|
Compugen Ltd. (CGEN) to Present at the Molecular Medicine Tri-Conference 2013 in San Francisco
2/5/2013 6:14:38 AM
More...
|
Compugen Ltd. (CGEN) Presents at American Association of Cancer Research Special Conference on Tumor Immunology
12/4/2012 10:57:53 AM
More...
|
Compugen Ltd. (CGEN) Announces $15 Million Funding Agreement for Its Keddem Subsidiary
11/19/2012 7:12:28 AM
More...
|
Compugen Ltd. (CGEN) to Present at Jefferies and Co. 2012 Global Healthcare Conference
11/14/2012 9:14:43 AM
More...
|
Compugen Ltd. (CGEN) Announces Discovery of Two Novel Immune Checkpoint Targets for Cancer Immunotherapy
10/31/2012 7:33:37 AM
More...
|
Compugen Ltd. (CGEN) Postpones Issuance of Third Quarter 2012 Report and Associated Conference Call to November 5, 2012, Due to Expected Severe Weather Conditions
10/29/2012 8:32:36 AM
More...
|
|